Table 2.
Placebo (n = 45) | Lutein/zeaxanthin (n = 45) | p-value | ||
---|---|---|---|---|
Age | Mean | 60.04 | 58.78 | 0.480a |
SE | 1.27 | 1.26 | ||
Sex | Female (n) | 35 | 36 | 0.796b |
Male (n) | 10 | 9 | ||
BMI | Mean | 27.12 | 27.20 | 0.934a |
SE | 0.59 | 0.67 | ||
Systolic blood pressure (mmHg) | Mean | 126.60 | 128.89 | 0.501a |
SE | 2.29 | 2.50 | ||
Diastolic blood pressure (mmHg) | Mean | 82.58 | 82.89 | 0.866a |
SE | 1.17 | 1.42 | ||
Marital status | Single | 18 | 11 | 0.114b |
Married/ defacto | 27 | 34 | ||
Educational level | Secondary | 20 | 16 | 0.435b |
Tertiary | 17 | 16 | ||
Post-graduate | 8 | 13 | ||
Exercise level (n) | Never/ rarely | 8 | 7 | 0.519b |
1 to 2 times a week | 5 | 10 | ||
3 to 5 times a week | 15 | 15 | ||
6+ times a week | 17 | 13 | ||
Taking any prescription medication | Yes | 21 | 26 | 0.291b |
Taking nutraceutical/ phytoceutical | Yes | 25 | 21 | 0.399b |
TICS score | Mean | 26.87 | 27.40 | 0.461a |
SE | 0.56 | 0.46 | ||
CFQ - Total score | Mean | 43.16 | 43.33 | 0.946a |
SE | 1.57 | 2.10 | ||
BRIEF-A Behavioral Regulation | Mean | 45.42 | 44.78 | 0.735a |
SE | 1.21 | 1.46 | ||
BRIEF-A Metacognition | Mean | 66.84 | 65.87 | 0.728a |
SE | 1.91 | 2.05 | ||
PROMIS-29 Physical Function | Mean | 18.98 | 19.18 | 0.593a |
SE | 0.28 | 0.25 | ||
PROMIS-29 Anxiety | Mean | 7.11 | 7.40 | 0.756a |
SE | 0.83 | 0.41 | ||
PROMIS-29 Depression | Mean | 6.07 | 6.44 | 0.503a |
SE | 0.42 | 0.38 | ||
PROMIS-29 Fatigue | Mean | 10.40 | 10.02 | 0.648a |
SE | 0.58 | 0.59 | ||
PROMIS-29 Sleep disturbances | Mean | 11.58 | 10.56 | 0.174a |
SE | 0.60 | 0.45 | ||
PROMIS-29 Ability to participate in social roles and activities | Mean | 16.18 | 16.16 | 0.977a |
SE | 0.57 | 0.54 | ||
PROMIS-29 Pain interference | Mean | 6.84 | 6.29 | 0.439a |
SE | 0.556 | 0.45 | ||
PROMIS-29 Pain intensity | Mean | 2.38 | 1.84 | 0.203a |
SE | 0.32 | 0.266 | ||
POMS-A Total Mood Disturbance | Mean | 90.69 | 91.02 | 0.914a |
SE | 1.84 | 2.46 |
Independent samples t-test;
Chi-square analysis.